AstraZeneca: The Key Statistics
Updated: 11:23am UK, Friday 02 May 2014
American pharmaceutical giant Pfizer, which makes Viagra, has until May 26 to confirm its intentions in what could be Britain's biggest ever takeover. Here are some key statistics and history about AstraZeneca:
:: Pfizer's original bid earlier this year for AstraZeneca valued the company at just under £60bn.
:: Its boosted bid on May 2 valued it at £63bn.
:: AstraZeneca operates in more than 100 countries and employs 51,500 people worldwide.
:: Around 9,000 of its staff work in research and development (R&D).
:: It attracted £15.6bn of annual sales in year ending December 31, 2013, however this was down 24% in two years - from £20.4bn in 2011.
:: Reported operating profits have fallen from £7.8bn to £2.2bn, a fall of 71% over the same period.
:: Key to these falling sales and profits is the loss of exclusivity on some of its blockbuster drugs including Arimidex, Atacand, Crestor, Nexium and Seroquel IR. In 2013, the loss of exclusivity directly reduced revenues by £1.3bn.
:: The group forecast that, with new drugs coming online and its extensive acquisition activity, revenues will be back in line with its 2013 figures by 2017.
:: In the three years to 2013, it has completed more than 150 acquisitions including Pearl Therapeutics and Omthera Pharmaceuticals.
:: In 2013, it bought Amplimmune for £700m to help the group secure future products.
:: Analysts see the group battling to sustain itself in a more competitive industry, where cheaper generics eat into the profits on successful drugs post exclusivity.
:: The R&D cost and difficulty of developing new equivalent blockbuster drugs keeps growing.
:: Pfizer's previous proposal on January 5 included a combination of cash and shares which represented an indicative value of £46.61 per AstraZeneca share.
:: The bid included a substantial premium of approximately 30% to AstraZeneca's closing share price of £35.86 on January 3.
:: AstraZeneca was formed in 1999 when Sweden's Astra - which was formed in 1913 - merged with the UK's Zeneca.
:: Zeneca was created in 1993 following a de-merger from ICI.
:: Pfizer's revenues were $51.6bn (£30.7bn) in 2013.
:: Pfizer employs 78,000 people worldwide including 900 in Britain.
:: It makes Viagra and Chap Stick.
Anda sedang membaca artikel tentang
Miliband Urges Caution On Pfizer Takeover Bid
Dengan url
http://kabarkomunitas.blogspot.com/2014/05/miliband-urges-caution-on-pfizer.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Miliband Urges Caution On Pfizer Takeover Bid
namun jangan lupa untuk meletakkan link
Miliband Urges Caution On Pfizer Takeover Bid
sebagai sumbernya
0 komentar:
Posting Komentar